Pyrimidoindole derivatives and processes for preparation thereof
CA 2025820 A1 · Owner: Kato, Masayuki · Inventors: Takasugi, Hisashi; Nishino, Shigetaka; Kato, Masayuki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compound of the formula:, wherein R1 R2 and R3 are each hydrogen, lower, alkyl lower alkenyl, aryl or ar(lower)alkyl, R4 is imidazolyl which may have suitable substituent(s) or pyridyl, A is lower alkylene and, ---- is single bond or double bond and pharma-, ceutically acceptable salts thereof. The preparation of these compounds, pharmaceutical compositions containing them and their use as a medicament are also disclosed. These compounds are useful for treating or preventing 5-hydroxytryptamine mediated diseases, for example, central nervous system (CNS) disorders such as psychosis (e.g. schizophrenia mania, etc.), anxiety, and depression; pains or aches such as headaches (e.g. migraine …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 20, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 20, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 20, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.